Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Serfaty

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Trials|January 15, 2025
Cross-agency working when conducting a pragmatic RCT for older victims of crime: our experiences and lessons learnedMarc Serfaty, Jessica Satchell, Gloria K Laycock, et al.
Health Technology Assessment (Winchester, England)|May 18, 2019
Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCTMarc Serfaty, Michael King, Irwin Nazareth, et al.
Trials|March 2, 2016
The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trialMarc Serfaty, Michael King, Irwin Nazareth, et al.
The Cochrane Database of Systematic Reviews|May 9, 2023
Antidepressants for pain management in adults with chronic pain: a network meta-analysisHollie Birkinshaw, Claire M Friedrich, Peter Cole, et al.
BMJ Open|July 25, 2025
The VIP trial: a randomised controlled trial of the clinical effectiveness of a Victim Improvement Package (VIP) for the reduction of continued symptoms of depression or anxiety in older victims of community crime in an English cityMarc Serfaty, Jessica Satchell, Teresa Lee, et al.
Psycho-Oncology|December 5, 2018
Acceptance and commitment therapy for adults with advanced cancer (CanACT): A feasibility randomised controlled trialMarc Serfaty, Megan Armstrong, Victoria Vickerstaff, et al.
Trials|February 12, 2016
Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trialJoseph Low, Marc Serfaty, Sarah Davis, et al.
Public Health Research (Southampton, England)|April 20, 2026
The Clinical and Cost-Effectiveness of a Victim Improvement Package (VIP) for the Reduction of Chronic Symptoms of Depression or Anxiety in Older Victims of Community-Crime: the VIP RCT SynopsisMarc Serfaty, Jessica Satchell, Anthony Kessel, et al.
Health Technology Assessment (Winchester, England)|November 11, 2025
Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson's disease: the ADepT-PD RCT pilotAnette Schrag, Camille Carroll, Glyn Lewis, et al.
Trials|April 18, 2020
The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trialMarc Serfaty, Trefor Aspden, Jessica Satchell, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Trials|January 15, 2025
Cross-agency working when conducting a pragmatic RCT for older victims of crime: our experiences and lessons learnedMarc Serfaty, Jessica Satchell, Gloria K Laycock, et al.
Health Technology Assessment (Winchester, England)|May 18, 2019
Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCTMarc Serfaty, Michael King, Irwin Nazareth, et al.
Trials|March 2, 2016
The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trialMarc Serfaty, Michael King, Irwin Nazareth, et al.
The Cochrane Database of Systematic Reviews|May 9, 2023
Antidepressants for pain management in adults with chronic pain: a network meta-analysisHollie Birkinshaw, Claire M Friedrich, Peter Cole, et al.
BMJ Open|July 25, 2025
The VIP trial: a randomised controlled trial of the clinical effectiveness of a Victim Improvement Package (VIP) for the reduction of continued symptoms of depression or anxiety in older victims of community crime in an English cityMarc Serfaty, Jessica Satchell, Teresa Lee, et al.
Psycho-Oncology|December 5, 2018
Acceptance and commitment therapy for adults with advanced cancer (CanACT): A feasibility randomised controlled trialMarc Serfaty, Megan Armstrong, Victoria Vickerstaff, et al.
Trials|February 12, 2016
Acceptance and commitment therapy for adults with advanced cancer (CanACT): study protocol for a feasibility randomised controlled trialJoseph Low, Marc Serfaty, Sarah Davis, et al.
Public Health Research (Southampton, England)|April 20, 2026
The Clinical and Cost-Effectiveness of a Victim Improvement Package (VIP) for the Reduction of Chronic Symptoms of Depression or Anxiety in Older Victims of Community-Crime: the VIP RCT SynopsisMarc Serfaty, Jessica Satchell, Anthony Kessel, et al.
Health Technology Assessment (Winchester, England)|November 11, 2025
Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson's disease: the ADepT-PD RCT pilotAnette Schrag, Camille Carroll, Glyn Lewis, et al.
Trials|April 18, 2020
The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trialMarc Serfaty, Trefor Aspden, Jessica Satchell, et al.
Pageof 5